Skip to Content

Tag: Home Infusion Therapy


Drew Walk

Also Noted

Soleo Health earns URAC accreditation

June 9, 2021HME News Staff

FRISCO, Texas – Soleo Health’s Phoenix location has earned Specialty Pharmacy Accreditation from URAC, the leading independent accrediting organization focused on supporting the quality of health care through leadership, accreditation, measurement and innovation standards and programs. With this URAC Specialty Pharmacy Accreditation, Soleo Health Phoenix demonstrates the highest value and quality in delivering enhanced clinical services to patients, payers, manufacturers and providers....

Drew Walk, Home Infusion Therapy, Soleo Health, URAC Accreditation


Read Full Articlered right arrow icon

Also Noted

Upstate joins NHIA in COVID treatment program

June 2, 2021HME News Staff

SYRACUSE, N.Y. – Upstate HomeCare has partnered with the National Home Infusion Therapy Association to offer monoclonal antibody therapies to patients with mild and moderate COVID-19. The NHIA COVID-19 Home Infusion Therapy (C-HIT) Program hosts an online listing of home infusion providers that have agreed to provide these therapies to eligible individuals in their communities. “Upstate HomeCare is proud to be part of the U.S. health care response to the pandemic in our community,”...

Home Infusion Therapy, monoclonal antibody therapy, Upstate HomeCare


Read Full Articlered right arrow icon

Option Care hungry for M&A 

Specialty Providers

Option Care hungry for M&A 

May 14, 2021Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – With a tuck-in acquisition in the Southeast, a new state-of-the-art facility in Chicago and new therapies added to its chronic care portfolio, Option Care Health is laying the groundwork for sustainable growth, say company officials.  Option Care announced May 6 it had paid $18.5 million for Houston-based BioCureRx, a regional provider of certain chronic care therapies.  “While limited in size, the BioCure transaction signifies...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Option Care Health reports ‘solid’ results 

Specialty Providers

Option Care Health reports ‘solid’ results 

May 7, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $759.2 million for the first quarter of 2021, an increase of 7.6% compared to $705.4 million for the same period last year.   Gross profit was $165.5 million, or 21.8% of net revenue, and adjusted EBITDA was $52.2 million for the quarter.  “The Option Care Health team delivered solid financial results in the first quarter while continuing to lay the foundation for sustained growth,” said John Rademacher,...

Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Specialty Providers

InfuSystem enhances capabilities

April 22, 2021HME News Staff

ROCHESTER HILLS, Mich. – InfuSystem, a provider of infusion pump therapy and other health care services, has acquired the operating assets of OB Healthcare Corporation, a privately held, Texas-based, biomedical services company.  The acquisition complements InfuSystem’s acquisition in February of FilAMed, a biomedical services company based in Bakersfield, Calif.   “This acquisition closely follows our purchase of FilAMed, which provides remote repair...

Home Infusion Therapy, InfuSystem Holdings, Rich Dilorio


Read Full Articlered right arrow icon

Also Noted

Virtis Health expands into Wisconsin 

April 21, 2021HME News Staff

PEWAUKEE, Wis. – Virtis Health, an alternate site provider of infusion services, has opened its first ambulatory infusion center in Wisconsin. Virtis Health Milwaukee will offer a range of therapy management services and treatments for patients with autoimmune disorders, including multiple sclerosis and myasthenia gravis. “We are bringing a highly personalized care model and clinical service to patients and physicians throughout greater Milwaukee with the new Virtis Health AIC,”...

ambulatory infusion, Home Infusion Therapy, Virtis Health


Read Full Articlered right arrow icon

Option Care sees growth driven by chronic care 

Specialty Providers

Option Care Health sees growth driven by chronic care 

March 26, 2021Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health saw double-digit growth in revenues as the company took advantage of its technology platform to respond to the disruption caused by the COVID-19 pandemic, said CEO John Rademacher on a recent earnings call.  Option Care Health reported net revenues of $804.7 million for the fourth quarter of 2020, an increase of 11.6% compared to the same quarter in 2019.  “Our ability to quickly pivot and utilize our technology...

Coronavirus Outbreak, Home Infusion Therapy, John Rademacher, Option Care Health


Read Full Articlered right arrow icon

Also Noted

Option Care Health to sell shares 

March 17, 2021HME News Staff

BANNOCKBURN, Ill. – Option Care Health has agreed to sell 12 million shares of the company’s common stock at $20 per share in an underwritten public offering. The selling stockholder, an affiliate of Madison Dearborn Partners, also granted the underwriter a 30-day option to purchase up to 1.8 million additional shares of common stock. The offering is expected to close today, March 17. This sale of shares represents approximately 6.7% of the current shares outstanding. Option Care...

Home Infusion Therapy, Option Care Health


Read Full Articlered right arrow icon

Also Noted

Soleo Health named exclusive provider of hemophilia services

September 4, 2020HME News Staff

FRISCO, Texas - Soleo Health has been named by AscellaHealth, a specialty pharmacy benefit manager, as an exclusive provider for the care and management of its members with hemophilia. AscellaHealth has a broad-based Hemophilia Management Program that includes an expanded budget that allocates significant resources for pharmacy costs. As a preferred provider, and through its SoleMetrics proprietary clinical outcomes program, Soleo Health will support AscellaHealth in its efforts to reduce costs and...

Home Infusion Therapy, Soleo Health


Read Full Articlered right arrow icon

Also Noted

Option Care Health selected to provide VILTEPSO

September 4, 2020HME News Staff

BANNOCKBURN, Ill. - Option Care Health has been chosen to participate in a limited distribution network for VILTEPSO (viltolarsen) for patients with Duchenne Muscular Dystrophy who are amenable to exon 53 skipping therapy. Viltepso is among a growing number of chronic infusion therapies for neuromuscular disorders that Option Care Health is able to deliver to patients at home or in one of the company's more than 125 ambulatory infusion suites across the country. “Our demonstrated track record...

Home Infusion Therapy, Option Care Health


Read Full Articlered right arrow icon